Acclarent Grants

Activities not supported through our educational grant process

The following types of activities are not eligible for educational grant support:

  • Programs not approved by Acclarent prior to the date of the event

  • Requests outside the areas of Acclarent business, educational and/or research interest
  • Requests from individual Health Care Professionals (HCP), group practices, commercial organizations or MECCs
  • Travel, expenses or fees for specific conference/society participants. As an exception, travel may be requested for HCPs in training, e.g. fellows, residents, medical students, if the request comes from the program sponsor or medical educational institution

Clinical Fellowship Funding

We're committed to working with medical institutions, thought-leaders, and other healthcare professionals to inspire innovation, educate patients and improve patient outcomes. Therefore, Acclarent is pleased to support educational grants for fellowship programs sponsored by teaching institutions, community hospitals or medical societies/associations that have a bona fide interest in, and track record of, advancing education and research in therapeutic areas of interest to Acclarent. Our fellowships are awarded to qualifying medical institutions or societies based on established criteria around the merit and rigor of the program, as well as funding availability.

Investigator Initiated Study Support

We accept unsolicited requests from independent researchers for funding and/or products to support independent research activities of legitimate interest to the Company and to advance patient care. The review process will likely take at least 90 days from the submission date of the completed application. All decisions regarding the Company's funding of grants and contributions are made independent of Sales and Marketing.

IIS proposals are reviewed to ensure that 1) the subjects' well-being is of primary importance, 2) Johnson & Johnson’s Credo-based values are considered in the design and conduct of the study, 3) the principles of good clinical and/or laboratory practice are applied, 4) product information is relevant, accurate, fair and balanced, and 5) medical and ethical concerns are raised and vetted.

If an application is approved, execution of a milestone-based contract is required for disbursement of the grant, and the investigator must attempt to present the research at a recognized educational forum and attempt to publish the study results in a peer-reviewed journal. This application process is intended for clinicians and scientists who are published and experienced in research.

Proposals must describe research that is unique and of scientific and business merit. Although the approval or denial of an individual request does not influence the review of subsequent proposals, reconciliation of any outstanding items from a previously approved grant to the same requestor or entity must be completed before anew proposal can be approved. To submit an Investigator Initiated Study research proposal for future funding consideration, please visit:

How do I submit an educational grant request?

To receive consideration, requests should be submitted at least 60 days prior to the start of the program. Submission of a grant request guarantees neither approval nor support for the entire amount requested (or any portion thereof).

Educational grant requests must be submitted using the link provided below. Our online portal guides you through the request process but we strongly recommend that you review the Frequently Asked Questions and Quick Reference Guide to ensure you have all the information you will need to complete the application.

If you are submitting in the portal for the first time, you will be asked to register in the system. This one-time step will save time when submitting future requests. Please have all required documents completed and available to submit as attachments before you begin the online application process.

Minimally, the following documentation must be uploaded with your grant request:

  • A signed letter of request on organizational/institutional letterhead describing the program
  • W-9 (completed with institution name, address, Federal Tax ID number, signed and dated)
  • A program agenda or brochure
  • Accreditation certificate (For accredited programs)

For assistance with the submission of Educational Grant requests:

If you would like assistance, please contact [email protected]

Budget — Attach the completed budget template to the grant request.



No applicable peer-reviewed references for this page.


Acclarent Navigation Technology is intended for use by or under the direction of a physician.  Devices guided by the Acclarent Navigation Technology have described risks including the potential for unintended injury to the orbits or CNS as a consequence of inaccurate navigation.  Prior to use, it is important to read the Instructions for Use and to understand the registration process and the contraindications, warnings and precautions described for the system.

ACCLARENT AERA® Eustachian Tube Balloon Dilation System is intended for use by physicians who are trained on Acclarent Technology. Eustachian tube balloon dilation has associated risks, including tissue and mucosal trauma, infection, or possible carotid artery injury.

ACCLARENT® Balloon Sinuplasty Devices are intended for use by or under the direction of a physician who is trained in the use of Acclarent Technology. ACCLARENT® Balloon Sinuplasty Device use has described risks, including tissue and mucosal trauma, infection, or possible orbital injury.

The RELIEVA TRACT™ Nasal Balloon Dilation System is an instrument intended to provide increased intranasal space to facilitate access for endonasal and trans-nasal procedures and/or temporarily address nasal obstruction by displacing the inferior turbinate and lower nasal septum. The RELIEVA TRACT™ Nasal Balloon Dilation System is intended for use in ages 17 years or older. Balloon dilation catheters should be used by or under supervision of physicians thoroughly trained in balloon dilation. A thorough understanding of the technical principles, clinical application, and risk associated with balloon dilation of the nasal passage is necessary before using this device.

Important Safety Information

Prior to use, it is important to read the Instructions for Use and to understand the registration process and the contraindications, warnings and precautions described for the systems.

Caution: Federal (US) law restricts the sale, distribution or use of these devices to, by or on the order of a physician. Third party trademarks used herein are trademarks of their respective owners. This content is intended for audience within the US only.

This site is published by Acclarent, Inc. which is solely responsible for its contents. It is intended for visitors from the United States.

© Acclarent, Inc. 2019. Last Updated on 10/11/2019